biospecimen__admin__batch_number	425.45.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	93CF9DEA-365B-4EC8-9FDD-331C394B192E
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-AACK-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-AACK-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-AACK-01A
biospecimen__bio__biospecimen_barcode_bottom	0174164349
biospecimen__bio__day_of_creation	04
biospecimen__bio__day_of_shipment	28
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	04
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-DD-AACK.B41B7C44-ED04-46EB-AD41-271456ECA762.pdf
biospecimen__bio__plate_column	3
biospecimen__bio__plate_id	A41H
biospecimen__bio__plate_row	A
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-DD-AACK
biospecimen__shared__patient_id	AACK
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	9D5F02DF-AC36-4D71-899F-CC298996A7AC
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.8
clinical__chol_lihc_shared__albumin_result_specified_value	4.6
clinical__chol_lihc_shared__albumin_result_upper_limit	5.3
clinical__chol_lihc_shared__bilirubin_lower_limit	0.2
clinical__chol_lihc_shared__bilirubin_upper_limit	0.9
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.7
clinical__chol_lihc_shared__creatinine_upper_limit	1.5
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.3
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	8
clinical__chol_lihc_shared__fetoprotein_outcome_value	5
clinical__chol_lihc_shared__fibrosis_ishak_score	6 - Established Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis B
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	1.0
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.0
clinical__chol_lihc_shared__platelet_result_lower_limit	130
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	0.9
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.2
clinical__chol_lihc_shared__vascular_tumor_cell_type	Micro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	70
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-AACK-F68369
clinical__clin_shared__bcr_followup_uuid	DE4295DC-7303-4BB1-94DC-23749B83A5C4
clinical__clin_shared__day_of_form_completion	15
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	2
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	YES
clinical__clin_shared__month_of_form_completion	7
clinical__clin_shared__platelet_result_count	98
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2008
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	None
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G2
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T1
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	55905b4a-c0cc-4dac-9212-23acb5cdf248
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-AACK-01A-11R-A41H-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	245d302c-12b3-4b33-a783-c13b7683873c
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.85
gdc__analytes__analyte_id	0cfc7456-ca88-4dc4-8790-4ff1d773d2aa
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	d7cd045a-0be2-4b6d-aefd-5d75e57bc6f6
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:30:09.587137-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	b6d828ea-2412-520e-8b9c-c3a693d575c3
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1938
gdc__diagnoses__age_at_diagnosis	25796
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-25796.0
gdc__diagnoses__days_to_last_follow_up	9.0
gdc__diagnoses__diagnosis_id	e76d1e75-d536-5f2a-b62d-3a542628817b
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage i
gdc__diagnoses__vital_status	alive
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	22.98539751216874
gdc__exposures__exposure_id	94315a0d-67f2-5bab-979b-58612af1c367
gdc__exposures__height	172.0
gdc__exposures__weight	68.0
gdc__file_id	68d0c0d4-c9d9-41aa-aeda-4fd76d54377f
gdc__file_name	610a0c74-2476-49c5-847f-9d0db6ee0895.mirbase21.mirnas.quantification.txt
gdc__file_size	50180
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	da3e4c7540362975f7997eb96ba650f0
gdc__portions__is_ffpe	false
gdc__portions__portion_id	6e8be685-1966-481a-9b55-70a38eccae75
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	1828
gdc__samples__initial_weight	140.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	B41B7C44-ED04-46EB-AD41-271456ECA762
gdc__samples__sample_id	9d81f1db-2a62-4ac1-b7d3-2f7b18f0ec1e
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	3.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	1.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	20.0
gdc__slides__percent_tumor_cells	80.0
gdc__slides__percent_tumor_nuclei	80.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	3953f2c5-ec07-436a-a030-c0bb621cbf02
gdc__submitter_id	mirna_swap_dr11_70_MirnaExpressiona535885e-71c4-410f-b7c5-6462168204d6_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	d9f2b14b-2150-56c6-a8f9-e393a8dc75c5
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:08:32.816+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/55905b4a-c0cc-4dac-9212-23acb5cdf248-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/55905b4a-c0cc-4dac-9212-23acb5cdf248-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129551
manually_curated__local_md5	2236ad6095d04f3b4363bd46a41c0cbf
manually_curated__opengdc_download_date	2018-10-16T17:10:37.000844+02:00
manually_curated__opengdc_file_md5	a170571c846efacf0a25b8c7e8060b0a
manually_curated__opengdc_file_size	50179
manually_curated__opengdc_id	55905b4a-c0cc-4dac-9212-23acb5cdf248-meq
manually_curated__origin_file_size	129551
manually_curated__origin_last_modified_date	Tue Oct 16 17:45:00 CEST 2018
manually_curated__origin_md5	2236ad6095d04f3b4363bd46a41c0cbf
manually_curated__tissue_status	tumoral
